Short covering fuels April rally, stock-specific action to continue in May
Analysts are identifying stock-specific opportunities for May following April’s short-covering rally. Bullish bets include Sun Pharma, Adani Ports, ONGC, Sona BLW, Bharti Airtel, ITC, and Kotak Mahindra Bank, with specific price targets and stop-losses. Conversely, Tata Motors Passenger Vehicles shows bearish sentiment with a potential downside target.
Third party premiums take the wheel in motor cover growth
TP premiums rose 9.3% in FY26, compared with 9% growth in OD, taking overall motor insurance expansion to about 9% on an estimated base of ?1.08 lakh crore. This contrasts with FY24, when OD grew a stronger 17.4% against roughly 10% for TP, supported by robust vehicle sales and pricing improvements. In FY25, OD grew […]
Nifty may keep to 23,500–24,800 range amid high oil prices, war uncertainty
Nifty is expected to trade within a narrow range of 23,500–24,800 due to geopolitical tensions and high oil prices. Analysts suggest a mildly positive bias, with specific trading strategies and stock picks like ITC and Tube Investments recommended for potential gains.
US Stock Market: Traders grapple with tail risk as stocks regain highs
US equities are nearing previous highs despite ongoing concerns about higher energy prices stemming from the Iran conflict. While tech earnings and Fed decisions fueled investor optimism, the persistent rise in oil prices continues to pose a risk of inflation and potential interest rate hikes, particularly in Europe.
Resurgent in April, can bulls defy ‘Sell in May’ maxim?
Indian stock markets may see continued gains in May. Investors should resist the urge to sell. While a repeat of April’s strong rally is unlikely, key indices have historically performed well in May. Moderate, stock-specific moves are expected. Elevated oil prices and a strong dollar could limit significant upside.
Tax shadow over charitable trusts with ‘profit’ motive
Three top-notch hospitals in Mumbai and a famous international spiritual organisation-all functioning as charitable trusts-have been denied Income tax (I-T) exemption on the grounds that they were carrying out commercial activities.
Pharma Q4 outlook mixed: Hospitals steady, generics face revlimid drag
Indian pharma and healthcare firms face a mixed March quarter. While hospitals anticipate steady growth, generic drugmakers grapple with lost Revlimid sales and pricing challenges. Lupin and Divi’s are poised for strong performance, with Sun Pharma and Torrent showing resilience. Apollo Hospitals expects robust traction across its diverse segments.
10 Largecap stocks with strong upside potential of up to 50%! Do you own any?
Analyst forecasts highlight 10 largecap stocks with 30–50% upside potential over 12 months, based on consensus estimates, offering investors data-driven opportunities across sectors with strong buy ratings and growth outlooks.
10 penny stocks surged up to 490% in 6 months. Do you own any?
Ten penny stocks surged up to 490% in six months, led by micro-cap momentum plays. Despite high returns, investors face risks like volatility, low liquidity, requiring careful research and disciplined risk management.
Mcap of four of top-10 most valued firms surges by Rs 2.20 lakh cr; Reliance biggest winner
The week began on a positive note, supported by easing geopolitical tensions and steady progress in Q4 earnings, which lifted initial sentiment, he said.However, gains were gradually capped by rising crude oil prices, weak cues from Asian markets, and persistent foreign institutional investor (FII) outflows, Mishra added.